All In MedTech

Device Trial Radar · NCT07689227

Closed-Loop Vagus Nerve Stimulation (CLV) for Recovery of Gait After Spinal Cord Injury (SCI)

Early Feasibility Study of the ReWire System for Closed-Loop Vagus Nerve Stimulation (CLV) Paired With Rehabilitation After Spinal Cord Injury (SCI) - Lower Limb Study

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Dec 30, 2026

Primary completion

Dec 2028

Study completion Dec 2028

Sponsor

Lead sponsor
The University of Texas at DallasAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
First posted
Jul 8, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety, feasibility, and preliminary effectiveness of the ReWire system, which delivers vagus nerve stimulation (VNS) paired with lower limb rehabilitation to improve gait in individuals with mobility impairments resulting from chronic, incomplete spinal cord injury (SCI).

Conditions

  • Spinal Cord Injury (SCI)
  • Gait
  • Reduced Physical Activity
  • Lower Limb Functions
  • Walking Impairment
  • Mobility Impairment
  • Functional Mobility

Interventions

  • CLVDevice

    The participants in this group will be implanted with the ReWire system and receive CLV in the double-blind phase

  • ShamDevice

    The participants in this group will be implanted with the ReWire system and receive Sham in the double-blind phase

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ReWire System SafetyTime frame: From device implantation to up to 2 years following implantation.
  2. ReWire System FeasibilityTime frame: All visits after implantation, up to approximately 26 weeks post-enrollment.

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Spaulding Rehabilitation Hospital, Mass General Brigham

    Boston, Massachusetts

  • Urgent Surgery Associates, PA

    Dallas, Texas

  • Baylor University Medical Center (BUMC)

    Dallas, Texas

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.